Most people can lose weight, but in this age group specifically, we are more concerned with long-term outcomes and I am not sure that putting these people on these meds forever is the way to achieve long-term weight loss, he said
April 8, 2025: MDL Against Ozempic and Other GLP-1s Top 1,600 in April As of April 1, 2025, there are 1,685 active lawsuits pending against Novo Nordisk and other pharmaceutical companies that sold GLP-1 drugs like Ozempic
Its not just breast cancer, either
While this intuition is reasonable, the evidence doesn't support itin fact, more frequent dosing of a long-acting medication can paradoxically increase side effect burden because you're introducing new doses before previous doses have peaked and declined
Step 4: Manage Everything Through the Medvi Patient Portal The Medvi patient portal acts as your main dashboard